Cladribine Venetoclax in Monocytic AML

Clinical trial NCT06232655 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06232655
Sponsor: University of Colorado, Denver
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2024-02-08
Primary completion: 2026-06-03
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.